Showing results (751-760 of 60,749) with videos related to
Sort By:
Pageof 6,075
Zootaxa|October 14, 2018
Description of a new Charinus species (Amblypygi: Charinidae) from the Monseñor Nouel province, Dominican RepublicMichael Seiter, Frederic D Schramm, Thomas SchwahaThe European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 16, 2000
Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?M Spannagl, L A Heinemann, W SchrammEuropean Journal of Anaesthesiology|December 3, 1999
Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosisC Schramm, R Wanitschke, P R GalleBiomolecular NMR Assignments|April 26, 2011
1H, 13C and 15N chemical shift assignments of IPSEΔNLSN Helge Meyer, Gabriele Schramm, Michael SattlerFortschritte Der Medizin|May 19, 1977
[Radioimmunoassay of fibrinopeptide A: double antibody method]W Schramm, M Schmid, F W ErhardtEmergency Medicine Journal : EMJ|August 18, 2018
Eighty-nine-year-old woman with abdominal pain and vomitingJoerg Schramm, Andreas Rickenbacher, Dagmar Iris KellerDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 1, 1985
[Diagnostic progress in malignant melanomas by high-resolution real-time sonography]W Kraus, A Nake-Elias, P SchrammDrugs Under Experimental and Clinical Research|January 1, 1996
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report)E Schramm, J W Nowicky, Y GodyshArchiv Fur Geschwulstforschung|January 1, 1976
[Testing of chemical substances, especially drugs, for carcinogenic activity in mammals (author's transl)]T Schramm, B Teichmann, K H HornHaemostasis|January 1, 1996
The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study GroupE Lechler, W Schramm, C W FlosbachPageof 6,075